Karla Kerlikowske

32.6k total citations · 7 hit papers
367 papers, 22.8k citations indexed

About

Karla Kerlikowske is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Karla Kerlikowske has authored 367 papers receiving a total of 22.8k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Oncology, 130 papers in Pulmonary and Respiratory Medicine and 105 papers in Cancer Research. Recurrent topics in Karla Kerlikowske's work include Global Cancer Incidence and Screening (240 papers), Digital Radiography and Breast Imaging (127 papers) and Breast Cancer Treatment Studies (103 papers). Karla Kerlikowske is often cited by papers focused on Global Cancer Incidence and Screening (240 papers), Digital Radiography and Breast Imaging (127 papers) and Breast Cancer Treatment Studies (103 papers). Karla Kerlikowske collaborates with scholars based in United States, United Kingdom and Australia. Karla Kerlikowske's co-authors include Diana L. Miglioretti, Diana S.M. Buist, Jeffrey A. Tice, Brian L. Sprague, Rebecca Smith‐Bindman, Bonnie C. Yankaskas, Berta M. Geller, Virginia L. Ernster, Patricia A. Carney and Steven R. Cummings and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Karla Kerlikowske

359 papers receiving 22.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography

2003 882 citations Patricia A. Carney, Diana L. Miglioretti et al. profile →
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

2000 794 citations Karla Kerlikowske et al. profile →
Hormone replacement therapy and endometrial cancer risk: A meta-analysis

1995 704 citations Karla Kerlikowske et al. profile →
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities

1998 483 citations Rebecca Smith‐Bindman, Karla Kerlikowske et al. JAMA profile →
National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium

2016 447 citations Brian L. Sprague, Diana S.M. Buist et al. Radiology profile →
Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection

2015 432 citations Diana S.M. Buist, Karla Kerlikowske et al. profile →
Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography

1996 405 citations Karla Kerlikowske JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karla Kerlikowske United States	81	11.9k	6.5k	5.4k	4.9k	4.2k	367	22.8k
Stephen W. Duffy United Kingdom	75	13.2k 1.1×	6.3k 1.0×	2.9k 0.5×	4.4k 0.9×	2.8k 0.7×	428	21.8k
Robert A. Smith United States	81	20.0k 1.7×	8.7k 1.3×	2.3k 0.4×	5.5k 1.1×	3.9k 0.9×	310	34.2k
William E. Barlow United States	76	7.6k 0.6×	3.4k 0.5×	1.8k 0.3×	3.5k 0.7×	2.1k 0.5×	277	19.9k
Carol DeSantis United States	32	13.0k 1.1×	5.1k 0.8×	912 0.2×	6.4k 1.3×	1.9k 0.4×	55	28.2k
Diana S.M. Buist United States	59	5.9k 0.5×	2.9k 0.4×	2.2k 0.4×	2.8k 0.6×	2.1k 0.5×	293	11.5k
Jonas Bergh Sweden	73	15.6k 1.3×	4.9k 0.8×	591 0.1×	11.6k 2.4×	2.8k 0.7×	521	29.1k
Antonio C. Wolff United States	71	15.9k 1.3×	4.9k 0.7×	642 0.1×	10.7k 2.2×	3.9k 0.9×	360	24.8k
Fátima Cardoso Portugal	68	13.8k 1.2×	4.9k 0.8×	773 0.1×	10.5k 2.1×	3.0k 0.7×	403	25.4k
Jenny Chang‐Claude Germany	64	6.6k 0.6×	2.7k 0.4×	1.0k 0.2×	2.5k 0.5×	1.9k 0.4×	361	15.1k
Anna N.A. Tosteson United States	73	6.1k 0.5×	3.0k 0.5×	2.6k 0.5×	1.4k 0.3×	2.3k 0.6×	348	24.6k

Countries citing papers authored by Karla Kerlikowske

Since Specialization

Citations

This map shows the geographic impact of Karla Kerlikowske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Kerlikowske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Kerlikowske more than expected).

Fields of papers citing papers by Karla Kerlikowske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karla Kerlikowske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Kerlikowske. The network helps show where Karla Kerlikowske may publish in the future.

Co-authorship network of co-authors of Karla Kerlikowske

This figure shows the co-authorship network connecting the top 25 collaborators of Karla Kerlikowske. A scholar is included among the top collaborators of Karla Kerlikowske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karla Kerlikowske. Karla Kerlikowske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kerlikowske, Karla, Weiwei Zhu, Yu‐Ru Su, et al.. (2024). Response to Omoleye, Esserman, Olufunmilayo. JNCI Journal of the National Cancer Institute. 116(4). 629–630. 3 indexed citations

George, Michaela F., et al.. (2024). Assessment of salivary cadmium levels and breast density in the Marin Women's Study. Cancer Medicine. 13(2). e6973–e6973. 2 indexed citations

Tosteson, Anna N.A., Karen E. Schifferdecker, Karen J. Wernli, et al.. (2022). Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. Journal of Women s Health. 31(11). 1547–1556. 2 indexed citations

Ravesteyn, Nicolien T. van, Clyde B. Schechter, John M. Hampton, et al.. (2021). Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women. JNCI Journal of the National Cancer Institute. 113(8). 1017–1026. 10 indexed citations

Bissell, Michael C. S., Karla Kerlikowske, Brian L. Sprague, et al.. (2020). Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status. Cancer Epidemiology Biomarkers & Prevention. 29(10). 2048–2056. 43 indexed citations

Engmann, Natalie J., Christopher G. Scott, Matthew R. Jensen, et al.. (2019). Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition. Cancer Epidemiology Biomarkers & Prevention. 28(8). 1324–1330. 16 indexed citations

Ahern, Thomas P., Brian L. Sprague, Michael C. S. Bissell, et al.. (2017). Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiology Biomarkers & Prevention. 26(6). 938–944. 28 indexed citations

Engmann, Natalie J., Christopher G. Scott, Matthew R. Jensen, et al.. (2017). Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors. Cancer Epidemiology Biomarkers & Prevention. 26(6). 930–937. 36 indexed citations

Ziv, Elad, Jeffrey A. Tice, Brian L. Sprague, et al.. (2017). Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS ONE. 12(1). e0168601–e0168601. 10 indexed citations

10.

Shieh, Yiwey, Donglei Hu, Lin Ma, et al.. (2016). Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Research and Treatment. 159(3). 513–525. 105 indexed citations

11.

Reeves, Katherine W., Susan R. Sturgeon, Nicholas G Reich, et al.. (2015). The Effect of Change in Body Mass Index on Volumetric Measures of Mammographic Density. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1724–1730. 27 indexed citations

12.

Kerlikowske, Karla, Charlotte C. Gard, Brian L. Sprague, Jeffrey A. Tice, & Diana L. Miglioretti. (2015). One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 24(6). 889–897. 36 indexed citations

13.

Bertrand, Kimberly A., Rulla M. Tamimi, Christopher G. Scott, et al.. (2013). Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Research. 15(6). R104–R104. 141 indexed citations

14.

Buist, Diana S.M., Rod Walker, Erin J. Aiello Bowles, et al.. (2012). Screening Mammography Use among Current, Former, and Never Hormone Therapy Users May Not Explain Recent Declines in Breast Cancer Incidence. Cancer Epidemiology Biomarkers & Prevention. 21(5). 720–727. 6 indexed citations

15.

DeFilippis, Rosa Anna, Hang Chang, Nancy Dumont, et al.. (2012). CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues. Cancer Discovery. 2(9). 826–839. 152 indexed citations

16.

Harvey, Jennifer A., Charlotte C. Gard, Diana L. Miglioretti, et al.. (2012). Reported Mammographic Density: Film-Screen versus Digital Acquisition. Radiology. 266(3). 752–758. 33 indexed citations

17.

Phipps, Amanda I., Diana S.M. Buist, Kathleen E. Malone, et al.. (2010). Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes & Control. 22(3). 399–405. 72 indexed citations

18.

Kerlikowske, Karla, Andrea J. Cook, Diana S.M. Buist, et al.. (2010). Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use. Journal of Clinical Oncology. 28(24). 3830–3837. 164 indexed citations

19.

Kerlikowske, Karla, et al.. (2004). Prognostic characterisitics of breast cancer among postmenopausal hormone users in a screened population. Breast Diseases A Year Book Quarterly. 15(3). 12 indexed citations

20.

Smith‐Bindman, Rebecca, Karla Kerlikowske, Vickie A. Feldstein, et al.. (1998). Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities. JAMA. 280(17). 1510–7. 483 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact